The Role of Kt/V and Creatinine clearance on Assisting Optimization of Serum Phosphorus Levels among Patients on PD.

IF 3.2 Q1 UROLOGY & NEPHROLOGY Kidney360 Pub Date : 2024-10-11 DOI:10.34067/KID.0000000618
Jaime Uribarri, Murilo Guedes, Maria Ines Diaz Bessone, Lili Chan, Andres De La Torre, Ariella Mermelstein, Guillermo Garcia-Garcia, Jochen Raimann, Thyago Moraes, Vincent Peters, Stijn Konings, Doug Farrell, Shuchita Sharma, Adrian Guinsburg, Peter Kotanko
{"title":"The Role of Kt/V and Creatinine clearance on Assisting Optimization of Serum Phosphorus Levels among Patients on PD.","authors":"Jaime Uribarri, Murilo Guedes, Maria Ines Diaz Bessone, Lili Chan, Andres De La Torre, Ariella Mermelstein, Guillermo Garcia-Garcia, Jochen Raimann, Thyago Moraes, Vincent Peters, Stijn Konings, Doug Farrell, Shuchita Sharma, Adrian Guinsburg, Peter Kotanko","doi":"10.34067/KID.0000000618","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hyperphosphatemia is associated with poor outcome and is still very common in peritoneal dialysis (PD) patients. Since peritoneal phosphate clearance is closer to peritoneal creatinine clearance than urea clearance, we hypothesized that weekly creatinine clearance (CrCl) could be a better marker of serum phosphate in PD.</p><p><strong>Methods: </strong>In a retrospective observational study, data from adult PD patients were collected across five institutions in North and South America: LATAM, RRI, Mount Sinai Hospital, Hospital Civil de Guadalajara, and the BRAZPD cohort. All centers analyzed routinely available laboratory data, with exclusions for missing data on serum phosphate, CrCl, or urea Kt/V. A unified statistical protocol was employed across centers. Linear mixed-effect models examined associations between longitudinal serum phosphate levels, CrCl, and Kt/V. Adjustments were made for age, gender, and baseline phosphate binder usage. Mixed-effects meta-analysis determined the pooled effect size of CrCl and Kt/V on serum phosphate trajectories, adjusted for confounders.</p><p><strong>Results: </strong>There were 16,796 incident PD patients analyzed. Age, BMI, gender, PD modality, Kt/V and CrCl as well as serum phosphate varied significantly across the different cohorts, but >70% had residual renal function. For most cohorts, both CrCltotal and urea Kt/V associated negatively with serum phosphorus levels, and log-likelihood ratio tests demonstrate that models including CrCltotal have more predictive information than those including only urea Kt/V for the largest cohorts. Models including CrCltotal increase information predicting longitudinal serum phosphate levels irrespective of baseline urea Kt/V, age, use of phosphorus binder, and gender.</p><p><strong>Conclusions: </strong>CrCl was not more accurate in predicting serum phosphate than urea Kt/V, but its inclusion in multivariable models predicting serum phosphate added accuracy. In conclusion, both creatinine clearance and Kt/V are associated with phosphate levels, and using both biomarkers, instead of just one, may better assist in the optimization of serum phosphate levels.</p>","PeriodicalId":17882,"journal":{"name":"Kidney360","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney360","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34067/KID.0000000618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hyperphosphatemia is associated with poor outcome and is still very common in peritoneal dialysis (PD) patients. Since peritoneal phosphate clearance is closer to peritoneal creatinine clearance than urea clearance, we hypothesized that weekly creatinine clearance (CrCl) could be a better marker of serum phosphate in PD.

Methods: In a retrospective observational study, data from adult PD patients were collected across five institutions in North and South America: LATAM, RRI, Mount Sinai Hospital, Hospital Civil de Guadalajara, and the BRAZPD cohort. All centers analyzed routinely available laboratory data, with exclusions for missing data on serum phosphate, CrCl, or urea Kt/V. A unified statistical protocol was employed across centers. Linear mixed-effect models examined associations between longitudinal serum phosphate levels, CrCl, and Kt/V. Adjustments were made for age, gender, and baseline phosphate binder usage. Mixed-effects meta-analysis determined the pooled effect size of CrCl and Kt/V on serum phosphate trajectories, adjusted for confounders.

Results: There were 16,796 incident PD patients analyzed. Age, BMI, gender, PD modality, Kt/V and CrCl as well as serum phosphate varied significantly across the different cohorts, but >70% had residual renal function. For most cohorts, both CrCltotal and urea Kt/V associated negatively with serum phosphorus levels, and log-likelihood ratio tests demonstrate that models including CrCltotal have more predictive information than those including only urea Kt/V for the largest cohorts. Models including CrCltotal increase information predicting longitudinal serum phosphate levels irrespective of baseline urea Kt/V, age, use of phosphorus binder, and gender.

Conclusions: CrCl was not more accurate in predicting serum phosphate than urea Kt/V, but its inclusion in multivariable models predicting serum phosphate added accuracy. In conclusion, both creatinine clearance and Kt/V are associated with phosphate levels, and using both biomarkers, instead of just one, may better assist in the optimization of serum phosphate levels.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Kt/V 和肌酐清除率对协助优化肺结核患者血清磷水平的作用
背景:高磷血症与不良预后有关,在腹膜透析(PD)患者中仍很常见。由于腹膜磷酸盐清除率比尿素清除率更接近腹膜肌酐清除率,我们假设每周肌酐清除率(CrCl)可能是腹膜透析患者血清磷酸盐的更好指标:在一项回顾性观察研究中,我们在北美和南美的五家机构收集了成年腹膜透析患者的数据:在这项回顾性观察研究中,南北美洲的五家机构收集了成年帕金森病患者的数据:LATAM、RRI、西奈山医院、瓜达拉哈拉市立医院和巴西帕金森病队列。所有中心都分析了常规可用的实验室数据,但不包括血清磷酸盐、CrCl 或尿素 Kt/V 的缺失数据。各中心采用统一的统计方案。线性混合效应模型检验了纵向血清磷酸盐水平、CrCl 和 Kt/V 之间的关联。对年龄、性别和磷酸盐结合剂基线使用情况进行了调整。混合效应荟萃分析确定了CrCl和Kt/V对血清磷酸盐轨迹的总体效应大小,并对混杂因素进行了调整:共分析了 16,796 例 PD 患者。不同队列的年龄、体重指数、性别、帕金森病治疗方式、Kt/V和CrCl以及血清磷酸盐有显著差异,但70%以上的患者有残余肾功能。在大多数队列中,CrCltotal 和尿素 Kt/V 均与血清磷水平呈负相关,对数似然比检验表明,对于最大的队列,包括 CrCltotal 的模型比只包括尿素 Kt/V 的模型具有更多的预测信息。无论基线尿素 Kt/V、年龄、使用磷结合剂和性别如何,包括 CrCltotal 的模型都能增加预测纵向血清磷酸盐水平的信息:结论:在预测血清磷酸盐方面,CrCl并不比尿素Kt/V更准确,但将其纳入预测血清磷酸盐的多变量模型会增加准确性。总之,肌酐清除率和 Kt/V 均与磷酸盐水平相关,使用这两种生物标志物而非仅使用其中一种,可以更好地帮助优化血清磷酸盐水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Kidney360
Kidney360 UROLOGY & NEPHROLOGY-
CiteScore
3.90
自引率
0.00%
发文量
0
期刊最新文献
Higher Serum Alkaline Phosphatase is Risk for Death and Fracture: A Nationwide Cohort Study of Japanese Dialysis Patients. Novel Biomarkers and Imaging Tests for AKI Diagnosis in Patients with Cancer. Association of Fibroblast Growth Factor 23 and Cardiac Mechanics in the Cardiovascular Health Study. Bridging Policy and Practice: Reforming Prior Authorization in Kidney Care. Facility-Level Variation in Nephrology Care among Veterans after Urinary Stone Diagnosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1